CLINICAL_TRIALS
trial_result
· 2026-02-24
Clinical Trial Update: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix [Phase 3]
Summary
A Phase 3 trial evaluating nelfinavir as a radiosensitizer for locally advanced cervical cancer has completed. The update indicates completion of the study, wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tata Memorial Hospital | Conditions: Carcinoma Cervix,Stage III | Phase 3 | Status: COMPLETED